Tissue Regenix Share Discussion Threads

[luminoso] 14/12/2016 17:07

I was that daft. I sold these after interims. On watch list at moment.

[rayrac] 12/12/2016 19:36

Waste....of.....breath

So lm off....

[rayrac] 12/12/2016 07:55

I pop back now and again, to see how things are progressing....but I'm not out😇

Who would be that daft?

[bamboo2] 09/12/2016 19:58

sp, thanks for letting us know. Hope you find a good home for the capital.

[rayrac] 09/12/2016 17:22

I've been out all day, thought we would have finished more positive!

[swiss paul] 09/12/2016 15:40

Sorry guys am out - will pop back now and again to see how things are progressing

[...]


Best of luck to all at TRX and holders

[rafboy] 08/12/2016 08:34

Woodford increasing to 19% represents a great deal of confidence in TRX and their ability to show a decent return for investors. I for one am delighted to see their stake increase thus putting more shares in safe and stable hands.

[channel pirate] 07/12/2016 17:02

Must hold my hand up and say that as my very small portfolio was “overloaded221; in favour of TRX, and depleting my available cash funds to £38, then I have sold a few yesterday and today. Now I have a few £K cash to ‘play with’ and balance up the portfolio a bit better. I had added 2 small lots at 16.04p and 17.375p within the last 2 months, so selling them has made me a small 5/6% net profit. Still hold more than I should here, but feel that recent news has certainly de-risked the investment somewhat.

Six years ago after entertaining a M.D. and his wife for the week-end at my home I invested “lock stock and barrel” into M.D.’s company placing, only for the company to de-list from AIM three months later and they have never traded since - £250,000 life savings lost that’s why I am reduced to limited investing. Oh to have that £250,000 now and make some decent money here...........!!

[igbertsponk] 07/12/2016 15:40

Woodford must have heard I was adding.

[rayrac] 07/12/2016 13:26

The next thing will be moans about a cheap t/o. To late then!

Although Woodford would be keen on a high price! And have some backing!!

[rayrac] 07/12/2016 13:24

Another 2.5m shares to Woodford...now why would he do that, other than to boost the performance of a certain fund!

I'm amazed and disappointed that I'm the only one to make a comment on the thread.👉7999;👿
Do you work for a living?

[pj84] 06/12/2016 18:26

The Premier alliance is comprised of approximately 3,600 U.S. based hospitals and 120,000 other healthcare providers which will now have contracted access to DermaPure(R).

That looks like we might start to see a step change in revenues.

[igbertsponk] 06/12/2016 16:44

Hmm... bet its not my offshore trust who I told to buy this morning. No doubt they'll buy when its gone up even more!

[rayrac] 06/12/2016 16:40

Not bad...not bad!

[rayrac] 06/12/2016 10:29

I think we just need one more piece of good news and that should do the trick. The blind shall see?

[igbertsponk] 06/12/2016 08:19

Cracking news that. I might well add a few

[rayrac] 06/12/2016 07:58

Extremely good news! The floodgates are opening.

It's about time this bb became more active among investors. Some can't see a diamond...only glass!

[bamboo2] 06/12/2016 07:39

06 December 2016

Tissue Regenix Group plc

DermaPure secures GPO agreement with Premier, Inc.

Leeds, 06 December 2016 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company today announces Tissue Regenix Wound Care, Inc. has secured a Group Purchasing Organisation (GPO) contract with Premier Inc., a leading healthcare improvement company.

DermaPure has been awarded this contract under a 'Breakthrough Technology Agreement', which is awarded by the GPO after a thorough four step review process is completed and it is determined that the technology offers unique attributes to the other available treatment options.

The Premier alliance is comprised of approximately 3,600 U.S. based hospitals and 120,000 other healthcare providers which will now have contracted access to DermaPure(R).

Antony Odell, CEO, Tissue Regenix Group plc commented: "Approval under Premier's Breakthrough Technology Agreement marks a significant milestone for DermaPure(R). This confirms the unique characteristics of our patented dCELL(R) Technology, the powerful clinical evidence we have collected, and the remarkable outcomes it achieves in real world clinical situations."

[bamboo2] 03/12/2016 09:11

sp, Thanks for sharing the reply.

It does seem strange. We were told about the delay in the Meniscus clinical trial due to the change in the format, but a delay in date for Tendon was not made clear.

I always thought the Tendon [XT] was 2017 anyway!

I just checked and the Hardman report dicusses XT as being CE marked six months early in 2016. So I guess it has reverted to the original timescale?

Did you ask about Xenograft products being sold into the NHS?

Cheers

[swiss paul] 02/12/2016 23:26

My learned colleague says thus
Response from TRX, confirms slippage due to administrative delays in CE process....
"Thank you for your email.
Yes, you are correct. The slight hold up is a procedural delay with the CE mark approval process, which is unfortunately outside of our control. However, we do still expect that launch of the product will go ahead in H1 2017. "
So, nothing to get too concerned about.

My thoughts are - is it Annual or FY 2017?

[bamboo2] 28/11/2016 22:49

sp, The ACL [Orthopure XT] product always was 2017.

It's the Meniscus [Orthopure XM] that has gone astray for 2016 I think. This is because the format has been revised and trial patients are being implanted with the newer version. The trial is extended. This format will be the same as that offered in the US.

NHSBT has nothing to do with the xenograft products. They will be offered to the NHS in due course I would imagine.

[swiss paul] 28/11/2016 20:56

erm that Holy Grail that you are on about - did they ever find it?

Nicked from the other shop
But the CE mark promised before 'year end 2016' six months ahead of schedule seems now to have slipped back into H1 2017.

So read the RNS
No mention of NHS B&T so is this targeted at European / USA or wherever. Or when the annual results come out will it be another expense line.

[bamboo2] 28/11/2016 17:18

Ray, yes that right, using our xenograft saves a second operation, along with all the costs, reduced infection risk, faster rehabilitation etc etc.

There will be a sweet spot in the pricing of this product that will make its use a no-brainer. Obvs if they go too high it will not be as easy to sell.

The ACL is often repaired at the same time as meniscus, hence the two products go very well together. This is the Holy Grail of Ortho surgery that Houlihan-Burne referred to, off the shelf parts, stored at room temperature.

It's a shame that they are doing a new version of the meniscus as this will prob take another year to get to the same point as ACL.

[rayrac] 28/11/2016 11:56

Just found it!

Allograft vs. Autograft - DCIDS Tissue Bank - DCI Donor Services
tissuebank.dcids.org › patient-education
Allograft vs. Autograft. An autograft is a bone or tissue that is taken from a part of a person's own body and transplanted into another. Often, surgeons will use a person's own hamstring tendon to repair a damaged anterior cruciate ligament.

We have another winner!